U-TGTX

Q:TGTX - TG THERAPEUTICS INC - http://www.tgtherapeutics.com

13:49:10 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
TGTX - Q	0.2	41.29	·	41.38	0.1	41.35	+0.63	1.5	587.2	23,967	6,713	41.00 42.1299 40.15	56.74 10.83	13:32:58	Apr 21	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Up -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 6713

Date ET	Symbol	Type	Headline
2021-04-21 07:00	U:TGTX	News Release200	TG Therapeutics Announces Launch of the ULTRA-V Phase 3 Trial Evaluating the Triple Combination of UKONIQ ™ (umbralisib), Ublituximab, and Venetoclax
2021-04-16 07:30	U:TGTX	News Release200	TG Therapeutics Announces Positive Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at American Academy of Neurology 73rd Annual Meeting
2021-04-15 16:00	U:TGTX	News Release200	TG Therapeutics to Host Investor & Analyst Event to Preview Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis
2021-03-29 07:42	U:TGTX	News Release200	TG Therapeutics Completes Rolling Submission of Biologics License Application to the U.S. Food and Drug Administration for Ublituximab in Combination with UKONIQ ™(umbralisib) as a Treatment for Patients with Chronic Lymphocytic Leukemia

Date ET

Symbol

Type

Headline

2021-04-21 07:00

News Release

2021-04-16 07:30

News Release